| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 08/11/2005 | WO2005007635A3 Combretastatin derivatives with cytotoxic action |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 08/11/2005 | US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 08/11/2005 | CA2553573A1 Method for stabilizing macrolide compound |
| 08/10/2005 | CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors |
| 08/09/2005 | US6927300 Process for the preparation of Latanoprost |
| 08/09/2005 | US6927291 Method for the synthesis of 2′,3′-dideoxy-2′,3′-didehydronucleosides |
| 08/09/2005 | US6927057 Macrolide analogs |
| 08/09/2005 | US6926914 Proanthocyanidin-containing composition |
| 08/09/2005 | CA2231700C Prodrugs of aspartyl protease inhibitors |
| 08/04/2005 | WO2005070891A2 Compounds and methods of use |
| 08/04/2005 | WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
| 08/04/2005 | WO2005070427A1 Compounds for the sustained reduction of body weight |
| 08/04/2005 | WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof |
| 08/04/2005 | US20050171357 Process for preparing indolinone derivatives |
| 08/04/2005 | US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/04/2005 | CA2553966A1 Vanilloid receptor ligands and their use in treatments |
| 08/04/2005 | CA2553649A1 Compounds for the sustained reduction of body weight |
| 08/03/2005 | EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 08/03/2005 | EP1429750A4 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 08/03/2005 | EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
| 08/02/2005 | US6924376 Compounds, compositions and methods |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
| 07/28/2005 | US20050165045 Compounds and methods |
| 07/28/2005 | US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders |
| 07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
| 07/28/2005 | CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/27/2005 | EP1556030A2 Taxane metabolites |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | CN1212322C Synthesis of 2,2'3,3'-benzophenone tetracidic dianhydride |
| 07/21/2005 | WO2005066162A1 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer |
| 07/21/2005 | WO2005066156A1 Selective kinase inhibitors |
| 07/21/2005 | WO2005066151A2 Histone deacetylase inhibitors |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004050609A8 Substituted ureas and carbamates |
| 07/21/2005 | US20050159477 Prepared by suspending pseudomonic acid in water and gradually adding calcium hydroxide to pH of 7.8-8.5, filtering, and lyophilizing frozen solution of calcium pseudomonate in water; stable topical pharmaceutical preparations |
| 07/21/2005 | US20050158240 Method for labeling with tritium |
| 07/20/2005 | EP1554270A2 Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642600A 1, 2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 07/20/2005 | CN1642599A ACC inhibitors |
| 07/20/2005 | CN1211361C Fused-ring carboxylic acid derivatives |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/14/2005 | WO2005063739A1 Novel quinoline derivatives |
| 07/14/2005 | WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/14/2005 | US20050154215 Extraction from Zanthoxylum naranjillo leaves; nuclear magnetic resonance; for treatment of Chaga's disease |
| 07/14/2005 | US20050154015 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050153998 Tetrahydroisoquinoline or isochroman compounds |
| 07/13/2005 | EP1553408A1 Fluorescent probe |
| 07/13/2005 | EP1553089A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551228A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 07/13/2005 | CN1639154A Pyranones useful as ATM inhibitors |
| 07/13/2005 | CN1639146A Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 07/13/2005 | CN1639145A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1636987A Epoxy compound, preparation method thereof, and use thereof |
| 07/12/2005 | US6916844 Hydroxy pyranone derivative and preparation method thereof |
| 07/12/2005 | CA2247167C 2-hetaroylcyclohexane-1,3-diones |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 07/07/2005 | US20050148777 (2R)-6-chloro-7-isobutyl-2-(trifluoromethyl)-2H-chromene-3-carboxylic acid; cyclooxygenase-2 mediated disorders |
| 07/07/2005 | US20050148659 Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148627 Benzopyran compounds for use in the treatment and prevention of inflammation related conditions |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/06/2005 | EP1550657A1 Amine compounds and use thereof |
| 06/30/2005 | WO2005058812A2 Prostaglandin synthesis |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005035504A3 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 06/30/2005 | US20050143447 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 06/30/2005 | US20050143446 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143373 Benzodioxole derivatives |
| 06/30/2005 | US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders |
| 06/30/2005 | CA2854783A1 Prostaglandin synthesis |
| 06/30/2005 | CA2549056A1 Prostaglandin synthesis |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |
| 06/29/2005 | EP1548121A1 Novel physiologically active substances |
| 06/29/2005 | EP1546152A1 Epothilone derivatives |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | CN1633432A Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/28/2005 | US6911549 Method of preparing a taxol derivative |
| 06/23/2005 | WO2005056549A1 Water-soluble etoposide analogs and methods of use thereof |
| 06/23/2005 | WO2005037272A8 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 06/23/2005 | WO2005033070A3 Method for the production of bisepoxides and dithiols |